- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CCRT+PF
Total 2440 results
-
PfizerCompleted
-
PfizerCompleted
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
PfizerCompletedInfluenza, HumanUnited States
-
Shanghai Proton and Heavy Ion CenterNot yet recruitingLocally Recurrent Nasopharyngeal CarcinomaChina
-
Medtronic Bakken Research CenterMedtronic; Medtronic Japan Co., Ltd.CompletedHeart Failure | Left Bundle-Branch Block | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV | Heart Failure With Reduced Ejection Fraction (HFrEF)Korea, Republic of, Japan, Singapore, Taiwan, Hong Kong, Indonesia, Malaysia, China, Philippines, Brunei Darussalam
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart Failure With Left Bundle Branch BlockKorea, Republic of, Spain, United States, Netherlands, Taiwan, France, Denmark, Italy, Sweden, Switzerland, Germany, Belgium, Finland, Japan, Poland, United Kingdom, Canada, Australia, Saudi Arabia, Hungary, India, Norway, Slovakia, A... and more
-
Sun Yat-sen UniversityActive, not recruiting
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...TerminatedHealthy SmokersUnited States
-
PfizerCompleted
-
PfizerCompletedDiabetes Melliuts, Type 2United States
-
Ruijin HospitalRecruitingCervical Cancer | Immunotherapy | ChemoradiotherapyChina
-
PfizerTerminated
-
PfizerCompletedHealthy SubjectsUnited States
-
PfizerTerminatedGastric Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Gastroesophageal Junction Cancer | Urothelial Cancer | Head and Neck Squamous Cell CarcinomasUnited States, Japan
-
Fred Hutchinson Cancer CenterPfizerTerminatedChronic Graft Versus Host Disease | FasciitisUnited States
-
PfizerCompletedHematologic MalignanciesUnited States, Italy
-
PfizerCompletedColorectal Cancer | Pancreatic Cancer | Cachexia | Non-Small-Cell Lung CancerUnited States
-
NCIC Clinical Trials GroupPfizerCompletedMalignant Pleural MesotheliomaCanada
-
PfizerActive, not recruitingDuchenne Muscular DystrophyUnited States
-
PfizerCompletedHealthy ParticipantsUnited States
-
PfizerCompletedHemophilia A or BPoland, Switzerland, South Africa, United States, Croatia, Brazil, Chile
-
PfizerTerminatedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Japan, Italy
-
PfizerTerminated
-
PfizerTerminatedAstrocytoma | Malignant Glioma | OligodendrogliomaUnited States
-
PfizerTerminatedTriple Negative Breast NeoplasmsSpain, United Kingdom, United States, Italy, Hungary, Poland
-
PfizerCompletedLupus Erythematosus, SystemicUnited States, Germany, Taiwan, Hungary, Poland, Colombia, Argentina, Romania, Chile, Puerto Rico, Korea, Republic of, Moldova, Republic of, Peru
-
PfizerCompleted
-
University Health Network, TorontoPfizerCompletedHead and Neck Squamous Cell CarcinomaCanada
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompletedSolid TumorsUnited States, Belgium
-
PfizerTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerBristol-Myers SquibbCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted